https://www.selleckchem.com/products/scr7.html
0001), glucose (p=0.02), insulin (p=0.03), liver fat (p=0.007) and liver stiffness (p=0.05). At 12 months follow-up, both glucagon and liver fat increased and were not different to basal levels, despite persistent reductions of BMI (p0.002) and glucose (p=0.008). In obese type-2 diabetic subjects, plasma glucagon and liver fat are correlated and similarly affected by a very low-calorie diet, supporting a role of hepatic steatosis in glucagon metabolism. In obese type-2 diabetic subjects, plasma glucagon and liver fat are correlated and
Like
Comment
Share
